|
1
|
Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.
|
Blood
|
2005
|
1.99
|
|
2
|
The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.
|
Blood
|
2006
|
1.94
|
|
3
|
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
|
J Clin Oncol
|
2007
|
1.88
|
|
4
|
Galectin-1: a link between tumor hypoxia and tumor immune privilege.
|
J Clin Oncol
|
2005
|
1.45
|
|
5
|
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
|
Blood
|
2011
|
1.41
|
|
6
|
Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes.
|
Am J Pathol
|
2007
|
1.30
|
|
7
|
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy.
|
Lab Invest
|
2007
|
1.16
|
|
8
|
Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases.
|
Am J Clin Pathol
|
2008
|
1.10
|
|
9
|
Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival.
|
Blood
|
2006
|
1.09
|
|
10
|
TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.
|
Am J Surg Pathol
|
2012
|
1.00
|
|
11
|
Extracellular signal-regulated kinase positively regulates the oncogenic activity of MCT-1 in diffuse large B-cell lymphoma.
|
Cancer Res
|
2009
|
0.99
|
|
12
|
Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation.
|
Nat Commun
|
2013
|
0.98
|
|
13
|
Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling.
|
Cancer Res
|
2004
|
0.95
|
|
14
|
The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.
|
Am J Clin Pathol
|
2009
|
0.94
|
|
15
|
Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.
|
Mod Pathol
|
2010
|
0.92
|
|
16
|
Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.
|
Blood
|
2012
|
0.90
|
|
17
|
CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.
|
Am J Pathol
|
2012
|
0.90
|
|
18
|
Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms.
|
Haematologica
|
2007
|
0.86
|
|
19
|
Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease: an immunohistochemical analysis.
|
Am J Clin Pathol
|
2006
|
0.85
|
|
20
|
Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP).
|
Br J Haematol
|
2009
|
0.83
|
|
21
|
CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas.
|
Hum Pathol
|
2009
|
0.83
|
|
22
|
A novel method for making "tissue" microarrays from small numbers of suspension cells.
|
Appl Immunohistochem Mol Morphol
|
2005
|
0.82
|
|
23
|
Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia.
|
Am J Clin Pathol
|
2009
|
0.82
|
|
24
|
C-C chemokine receptor 1 expression in human hematolymphoid neoplasia.
|
Am J Clin Pathol
|
2010
|
0.78
|
|
25
|
Expression of the activating receptor, NKp46 (CD335), in human natural killer and T-cell neoplasia.
|
Am J Clin Pathol
|
2013
|
0.76
|
|
26
|
HGAL protein expression persists in disorders of germinal center dissolution: potential role of HGAL in the germinal center microenvironment.
|
Appl Immunohistochem Mol Morphol
|
2011
|
0.76
|
|
27
|
Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia.
|
Pediatr Dev Pathol
|
2007
|
0.75
|